Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:PRAH

PRA Health Sciences (PRAH) Stock Price, News & Analysis

PRA Health Sciences logo

About PRA Health Sciences Stock (NASDAQ:PRAH)

Key Stats

Today's Range
$165.21
$165.21
50-Day Range
$165.21
$174.52
52-Week Range
$93.00
$175.95
Volume
57 shs
Average Volume
837,472 shs
Market Capitalization
$10.70 billion
P/E Ratio
50.52
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

PRA Health Sciences, Inc., a contract research organization, provides outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries worldwide. It operates in two segments, Clinical Research and Data Solutions. The Clinical Research segment offers product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations, data and programming, safety and risk management, biostatistics and medical writing, quality assurance, and late phase services. It also provides strategic solutions, such as embedded, functional services provider, staff augmentation, and custom-built development solutions, as well as commercialization services; and early development services for Phase I and Phase IIa studies, as well as bioanalytical analysis. The Data Solutions segment offers data, analytics, technology, and consulting solutions to the life sciences market. Its services include market intelligence services, such as targeting and compensation, and pharmaceutical audit suite services; consulting and services comprising brand analytics, managed markets, commercial effectiveness, and scientific studies/clinical hubs; and technology-enabled products and services that allow clients to access and analyze Symphony Health and integrated third-party data. PRA Health Sciences, Inc. conducts clinical trials in the areas of pharmaceutical development, including oncology, immunology, central nervous system, inflammation, respiratory, cardiometabolic, and infectious diseases. The company was formerly known as PRA Global Holdings, Inc. and changed its name to PRA Health Sciences, Inc. in July 2014. PRA Health Sciences, Inc. was founded in 1976 and is headquartered in Raleigh, North Carolina.

Receive PRAH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PRA Health Sciences and its competitors with MarketBeat's FREE daily newsletter.

PRAH Stock News Headlines

PRA Health Sciences
This Bull Market Indicator called NVDA at $116
Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…
PRAH Historical Data
Western University of Health Sciences
Mercy College of Health Sciences
See More Headlines

PRAH Stock Analysis - Frequently Asked Questions

PRA Health Sciences, Inc. (NASDAQ:PRAH) issued its quarterly earnings data on Wednesday, April, 28th. The medical research company reported $1.35 EPS for the quarter, topping analysts' consensus estimates of $1.32 by $0.03. The firm's revenue was up 19.1% on a year-over-year basis.

PRA Health Sciences (PRAH) raised $306 million in an IPO on Thursday, November 13th 2014. The company issued 17,000,000 shares at a price of $18.00 per share. Jefferies, Citigroup, KKR, UBS Investment Bank, Credit Suisse and Wells Fargo Securities served as the underwriters for the IPO and Baird and William Blair were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that PRA Health Sciences investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX), Visa (V) and JPMorgan Chase & Co. (JPM).

Company Calendar

Last Earnings
4/28/2021
Today
11/07/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Commercial Physical Research
Sub-Industry
N/A
Current Symbol
NASDAQ:PRAH
Fax
N/A
Employees
18,100
Year Founded
N/A

Profitability

Net Income
$197.04 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$3.18 billion
Cash Flow
$6.09 per share
Book Value
$23.06 per share

Miscellaneous

Free Float
N/A
Market Cap
$10.70 billion
Optionable
Optionable
Beta
1.31

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

This page (NASDAQ:PRAH) was last updated on 11/7/2024 by MarketBeat.com Staff
From Our Partners